BRAF and familial pancreatic carcinoma: An elevated l-serine level has been associated with tumor disease progression, a poor prognosis for tumor patients and resistance to BRAF inhibitors in melanoma, pancreatic cancer, and non-small cell lung cancer cells [49]; meanwhile, inhibition of l-serine synthesis significantly reduce tumor cell numbers [50].